Looking Into Takeda Pharmaceutical's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Takeda Pharmaceutical's (NYSE:TAK) short interest has decreased by 3.85% since the last report, with 7.88 million shares sold short, representing 0.25% of available shares. The average time to cover these short positions is 5.66 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Takeda has a lower short interest compared to its peer group average of 3.69%.
January 15, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Takeda Pharmaceutical's short interest has decreased, potentially indicating a more bullish sentiment among investors and a positive short-term impact on the stock.
The decrease in short interest suggests that fewer investors are betting against Takeda Pharmaceutical's stock, which could be taken as a positive sign by the market. However, short interest is just one of many factors that can affect stock prices, and the article does not guarantee a rise in the stock price. The confidence level is not at 100 because market sentiment can be unpredictable and influenced by various external factors.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100